0 items USD 0.00Search
Your search for "Hodgkin Lymphoma" gave back 549 results.
The global Hodgkin Lymphoma Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Publisher' newest research report, the “Non-Hodgkin Lymphoma Therapeutics Industry Forecast” looks at past sales and reviews total world Non-...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Adult Non-Hodgkin Lymphoma Treatment market size was valued at USD 7820 million in 2022 and is forecast to a readjusted size of USD 13440...
Catalog:
GIR
August 2023
Price: USD 3,480.00
According to our Publisher latest study, the global Non-Hodgkin Lymphoma Therapeutics market size was valued at USD million in 2022 and is forecast...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Industry Forecast” looks at past sales and reviews total world B-Cell Non-Hodgkin's...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Highlights The global Hodgkin Lymphoma Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Non-Hodgkin Lymphoma Therapeutics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Hodgkin's lymphoma is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Lymphoma Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Summary Lymphoma Drugs market research report provides the newest industry data and industry future trends, allowing you to identify the products and...
Catalog:
ICRW
December 2022
Price: USD 2,960.00
